Harris, David C.H.

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Floege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., Wetzels, J. F. M., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 263

Discrete functions of M 2a and M 2c macrophage subsets determine their relative efficacy in treating chronic kidney disease

Lu, J., Cao, Q., Zheng, D., Sun, Y., Wang, C., Yu, X., Wang, Y., Lee, V. W. S., Zheng, G., Tan, T. K., et al. (2013) · Kidney International

Renal Diseases and GlomerulopathiesImmune cells in cancer

Cited by 242

Characterization of murine macrophages from bone marrow, spleen and peritoneum

Wang, C., Yu, X., Cao, Q., Wang, Y., Zheng, G., Tan, T. K., Zhao, H., Zhao, Y., Wang, Y., & Harris, D. C. (2013) · BMC Immunology

Immune cells in cancerPhagocytosis and Immune Regulation

Cited by 225

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Levin, A., Agarwal, R., Herrington, W. G., Heerspink, H. L., Mann, J. F. E., Shahinfar, S., Tuttle, K. R., Donner, J.-A., Jha, V., Nangaku, M., et al. (2020) · Kidney International

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 125

Targeting inflammation with chimeric antigen receptor macrophages using a signal switch

Cao, Q., Wang, Y., Chen, J., Wang, R., Chen, T., Gloss, B., Read, S. A., Wang, X., Lee, V. W. S., Clancy, L., et al. (2025) · Nature Biomedical Engineering

CAR-T cell therapy researchImmune cells in cancer

Cited by 50